Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/1999
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012554A1 Chemical supplementation of bone
03/18/1999WO1999012537A1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
03/18/1999WO1999012533A1 A method of modulating cellular activity
03/18/1999WO1999012529A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
03/18/1999WO1999012524A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012521A1 New foam-forming pharmaceutical composition
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303347A1 Chemical supplementation of bone
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302710A1 New foam-forming pharmaceutical composition
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2301883A1 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect
03/17/1999EP0901465A1 Compounds with anti-inflammatory and immunosuppressive activities
03/17/1999EP0901464A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
03/17/1999EP0901462A1 Bi-aromatic compounds, compositions containing them and uses
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901376A1 Malatonin in combination with analgesics
03/17/1999EP0901373A1 Alpha v Beta 3 ANTAGONISTS
03/17/1999EP0901372A1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
03/17/1999EP0901370A1 Stimulation of immune response with low doses of il-2
03/17/1999EP0799231B1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents
03/17/1999EP0733065B1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
03/17/1999EP0708774B1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1210859A New benzimidazole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them
03/16/1999US5883293 Conformationally constrained backbone cyclized peptide analogs
03/16/1999US5883251 Enzyme inhibitors
03/16/1999US5883239 aroA
03/16/1999US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883102 Pharmaceutically active compounds
03/16/1999US5883075 Hypotensive agent cyclic peptides
03/16/1999US5882896 M protein
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA2167198C Benzylaminoquinuclidines
03/16/1999CA2160140C Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
03/16/1999CA2150709C Pyrazolopyrimidines
03/16/1999CA2058264C Dihydrobenzofuran carboxamides and process for their preparation
03/16/1999CA1340444C Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
03/11/1999WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
03/11/1999WO1999011666A1 N-terminal modifications of rantes and methods of use
03/11/1999WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
03/11/1999WO1999011637A1 Protease inhibitors
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011608A1 Malonic acid based matrix metalloproteinase inhibitors
03/11/1999WO1999011605A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1998056771A3 Piperazine derivatives and their use as anti-inflammatory agents
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999DE19738855A1 Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht Transdermal therapeutic system with contact adhesive reservoir layer and unidirectional elastic backing
03/11/1999CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999CA2302361A1 Protease inhibitors
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2302037A1 Malonic acid based matrix metalloproteinase inhibitors
03/11/1999CA2300046A1 N-terminal modifications of rantes and methods of use
03/11/1999CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
03/10/1999EP0900559A1 Use of a dispersion based on lipid vesicles as an anti-inflammatory composition
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900235A1 Fragments of cr1 and their use
03/10/1999EP0900225A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
03/10/1999EP0900212A1 Chiral phenyldihydrofuranones as pde-iv inhibitors
03/10/1999EP0900203A1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis
03/10/1999EP0900198A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900080A1 Novel indole and benzothiazole derivatives
03/10/1999EP0733049B1 Tricyclic derivatives and their use in pharmaceuticals
03/10/1999EP0722438B1 Hydroxamic acid derivatives as inhibitors of cytokine production
03/10/1999EP0714386B1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
1 ... 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 ... 1272